IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 8612 
Small font sizeDefault font sizeIncrease font size
Navigate Here
 » Next article
 » Previous article 
 » Table of Contents
Resource Links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »  Article in PDF (440 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)

In This Article
 »  Abstract
 »  Introduction
 »  Material and Methods
 »  Results
 »  Discussion
 »  Acknowledgements
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    PDF Downloaded404    
    Comments [Add]    
    Cited by others 8    

Recommend this journal


Year : 2010  |  Volume : 42  |  Issue : 4  |  Page : 234-237

Evaluation of Cassia occidentalis for in vitro cytotoxicity against human cancer cell lines and antibacterial activity

School of Biotechnology, University of Jammu, Jammu, India

Date of Submission19-Nov-2008
Date of Decision13-Aug-2009
Date of Acceptance26-Jun-2010
Date of Web Publication13-Aug-2010

Correspondence Address:
Madhulika Bhagat
School of Biotechnology, University of Jammu, Jammu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0253-7613.68428

Rights and Permissions

 » Abstract 

Objective : To evaluate the in vitro cytotoxicity and antibacterial properties of Cassia occidentalis (whole plant) via alcoholic, hydro-alcoholic, and aqueous extracts against eight human cancer cell lines from six different tissues and four bacterial strains.
Material and Methods : In vitro cytotoxicity against the human cancer cells, cultured for 48h in presence of different concentrations C. occidentalis extracts and percentage of cell viability, was evaluated using the sulforhodamine-B (SRB) assay. The antibacterial activity was performed using the standard protocol against bacterial strains.
Results : It was observed that aqueous extract of C. occidentalis (whole plant) had more potential than hydro-alcoholic and alcoholic extracts against HCT-15, SW-620, PC-3, MCF-7, SiHa, and OVCAR-5 human cancer cell lines at 100, 30, and 10 μg/ml in a dose-dependent manner. The hydro-alcoholic extract showed potential against Bacillus subtillis.
Conclusion : The plant can be explored for the possible development of lead molecules for drug discovery.

Keywords: Antibacterial activity, Cassia occidentalis, cytotoxicity

How to cite this article:
Bhagat M, Saxena AK. Evaluation of Cassia occidentalis for in vitro cytotoxicity against human cancer cell lines and antibacterial activity. Indian J Pharmacol 2010;42:234-7

How to cite this URL:
Bhagat M, Saxena AK. Evaluation of Cassia occidentalis for in vitro cytotoxicity against human cancer cell lines and antibacterial activity. Indian J Pharmacol [serial online] 2010 [cited 2023 Oct 5];42:234-7. Available from: https://www.ijp-online.com/text.asp?2010/42/4/234/68428

 » Introduction Top

Approximately 80% of the world's population still relies on traditional medicines for the treatment of common illnesses. [1] It is observed that management of cancer and infectious diseases always require search for new drugs. Although numerous drugs are currently in use for cancer chemotherapy, they exhibit cell toxicity, induces genotoxic, carcinogenic, and teratogenic effects in non-tumor cell. [2] These side effects limit use of chemotherapeutic agents despite their high efficacy in treating target malignant cells. Similarly, antibacterial drug resistance has been a therapeutic problem. [3] Therefore, the search for novel drugs that are both effective and non-toxic bioactive plant products has been increased. [4] Cassia occidentalis (Leguminosae) plant has been extensively used in indigenous and folk-lore medicine system. In Indian system of medicine the plant has been documented as thermogenic, puragative, expectorant, diuretic, and used in the treatment of leprosy, erysipelas, ulcers, cough, bronchitis, constipation, flatulence, dyspepsia, menstrual problems, tuberculosis, and anemia. [5] Reports for its immunosuppressive, [6] antimutagenic, [7] anti-inflammatory, [8] anti-dermatophyte, [9] antibacterial, [10] antiplasmodial, [11] anti-fertility, [12] antimalarial, [13] and antidiabetic [14] activities had been published. The leaf extracts of the plant have been reported to repair, protect, and normalize the liver functions. [15] Considering the therapeutic values of C. occidentalis, the present work was undertaken to evaluate the in vitro cytotoxic and antibacterial activity.

 » Material and Methods Top

Chemical Agents

RPMI- 1640, Dulbecco's minimum essential medium (DMEM), fetal calf serum (FCS), trypsin, gentamycin, penicillin, ethylene diaminetetraacetic acid (EDTA), 5-flurouracil, dimethyl sulfoxide, and sulforhodamine-B were purchased from Sigma Chemical Co., USA. All other chemicals were of high purity and obtained locally.

Plant Material

Whole plant of C. occidentalis was collected locally in the month of December and was authenticated at source by the taxonomist of the institute. A voucher specimen has been deposited at the herbarium of the Institute vide IIIM collection No.17687, Acc. No.19361.

Preparation of Extracts

The authenticated and freshly collected whole plant was chopped and dried under shade. Three extracts of the plant material were made with 95% alcohol, alcohol-water (1:1), and water using repeated solvent extraction procedure. Dried powdered plant material (1 kg) was percolated in 95% alcohol (5 L) at ambient temperature for 16 h. The solvent was decanted and the process was repeated four times. The pooled solvent was evaporated under reduced pressure to yield alcoholic extract (160 g). Similarly, hydro-alcoholic extract was prepared. The dried plant material (200 g) was soaked in alcohol:water (1:1, 1 L) and the extract obtained was 72 g. For aqueous extract the dried powdered plant material (200 g) was heated with distilled water (1.5 L) on steam bath for 2 h, the supernatant was decanted and filtered through celite powder and the process was repeated four times, pooled extract was concentrated on rotavapour and dried in a lyophilizer, and 40 g extract was obtained.

Cell Lines and Culture

The human cancer cell lines were obtained either from National Center for Cell Science, Pune, India, or National Cancer Institute, Fredrick, USA. The cell lines namely colon (HCT-15, SW-620, COLO 205), ovary (OVCAR-5), prostate (PC-3), and lung (HOP-62) were grown and maintained in RPMI-1640 medium, pH 7.4, whereas DMEM was used for breast (MCF-7) and cervix (SiHa).

In vitro Cytotoxicity against Human Tumor Lines

The in vitro cytotoxicity of extracts was determined using sulforhodamine-B (SRB) as described previously. [16] In brief, the stock solution (20 mg/ml) of the alcoholic, hydro-alcoholic, and aqueous extracts was prepared in dimethylsulfoxide (DMSO), dimethylsulfoxide - water (1:1) and hot water. The stock solutions were further diluted with growth medium (RPMI-1640/ DMEM with 2mM glutamine, pH 7.4, 10% fetal calf serum, 100 μg/ml streptomycin and 100 U/ml penicillin) to obtain desired concentrations. The cells were grown in tissue culture flasks in growth medium at 37οC in an atmosphere of 5% CO 2 and 95% relative humidity in a CO 2 incubator. The cells at subconfluent stage were harvested from the flask by treatment with trypsin (0.05% trypsin in PBS containing 0.02% EDTA) and suspended in the growth medium. Cells with more than 97% viability (Trypan blue exclusion) were used for determination of cytotoxicity. An aliquot of 100 μl of cell suspension (10 5 to 2 Χ10 5 cells/ml depending upon mass doubling time of cells) was transferred to a well of 96-well tissue culture plate and incubated for 24 h. The test materials (100 μl) were then added to the wells and incubated for another 48 h. The cell growth was stopped by 50 μl of 50% trichloroacetic acid and plates were further incubated at 4οC for an hour. The plates were washed with distilled water and air-dried. Sulforhodamine B (100 μl, 0.4% in 1% acetic acid) was added to each well and plates were incubated at room temperature for 30 min. The unbound SRB was removed by washing with 1% acetic acid and air-dried. Tris-HCL buffer (100 μl, 0.01 M, pH 10.4) was added to all the wells and stirrer. The optical density was recorded on ELISA reader at 540 nm. Suitable blanks and positive controls were also included. Each test was done in triplicate.

The percentage of cell viability was calculated according to the following equation.

OD of control cells

Statistical Analysis

The experiments were repeated three times and the results were expressed as mean ± SD.Statistical analysis was done using unpaired Student's t-test and P values < 0.01 were considered significant.

Antibacterial Assay

The antibacterial assays were performed using the standard protocols. [17]

 » Results Top

In vitro Cytotoxic Effect against Human Cancer Cell Lines

In vitro
cytotoxicity of all the three extracts (alcoholic, hydro-alcoholic and aqueous) of C. occidentalis (whole plant) was evaluated at 10, 30, and 100 μg/ml against eight human cancer cell lines from six different tissues origin, namely colon, prostate, breast, cervix, ovary, and lung [Figure 1]. Growth inhibition in a dose-dependent manner was observed in all the cell lines by all there extracts. It was also observed that aqueous extract was most active than hydro-alcoholic and alcoholic extract against all the human cancer cell lines except lung (HOP-62) cancer cell lines where the percent growth inhibition was less than 50%, in comparison to the positive control paclitaxel. When compared with the different positive controls (5-FU, mitomycin C, adriamycin, and paclitaxel) specific for different cell lines the growth inhibition of aqueous extract was found higher than other two extracts. At 100 μg/ml out of eight cancer cell lines aqueous extract showed more than 70% growth inhibition against four cancer cell lines, namely 81% against HCT-15 (colon), 76% against SW-620 (colon), 78% against SiHa (cervix), and 76% against OVCAR-5 (ovary) human cancer cell lines [Figure 1]. Further on lower doses of 30 and 10 μg/ml percent growth inhibition observed by aqueous extract was 71 and 43% against HCT-15 (colon), 64 and 40% against SW-620 (colon), and 76 and 42% against SiHa (cervix) human cancer cell lines. Hydro-alcoholic extract showed highest cytotoxicity against HEP-2, followed by COLO 205 with 96% and 89% growth inhibition at 100 μg/ml, further on lower doses of 30 and 10 μg/ml percent growth inhibition observed was 74 and 39% against HEP-2, 18, and 28 against COLO 205 human cancer cell lines, minimum cytotoxic effect by hydro-alcoholic extract was observed against MCF-7 cancer cell line, and for rest of the cancer cell lines growth inhibition was observed less than 70% at 100 μg/ml. The alcoholic extract showed comparatively less activity against all the eight human cancer cell lines [Figure 1].
Figure 1 :In vitro cytotoxicity of C. occidentalis extracts against human cancer cell lines.

Click here to view

Antibacterial Assay

The in vitro antibacterial activity of the three extracts of C. occidentalis (whole plant) was found less than that of chloramphenicol, which was used as standard. Out of all the three extracts, hydro-alcoholic extract demonstrated more sensitivity against Bacillus subtillis than alcoholic and aqueous extracts. Whereas all the three extracts were found to be inactive against  Escherichia More Details coli, Pseudomonas aeruginosa, and Staphylococcus aureus [Table 1].
Table 1 :Comparison of C. occidentalis extracts on the growth of bacterial species.

Click here to view

 » Discussion Top

The present study observed that the aqueous and hydroalcoholic extracts of C. occidentalis inhibits the proliferation of eight human cancer cell lines. The cytotoxicity effect was highest with aqueous extract and least for alcoholic extract. Although the activity demonstrated by the whole plant was low, this may be due to the crude nature of the extracts that can be further enhanced by the purification. The cytotoxicity was concentration-dependent and cell line specific. This clearly indicates the presence of potent bioactive principles in the crude extract that might be useful as antiproliferative and antitumoragents. [18] Although the mechanism of the action have not been elucidated, but there are report that aqueous extracts from leaves of C. occidentalis to contain flavonoids and antioxidant polyphenolic compounds. [19] These compounds are known to scavenge the formation of free radicals, have great potential in ameliorating disease processes like cancer and diabetes. [20] The extracts could have exerted its actions by some unknown mechanism ether alone or in combination. Thus the active principle(s) need to be identified.

Similarly, hydro-alcoholic extract of C. occidentalis showed potent antibacterial activity against Bacillus subtillis strain indicating the presence of chemical constituents responsible for antibacterial activity. The prokaryotic cell structure of a bacterial cell is different than eukaryotic cells. Therefore, both in vitro cytotoxicity and antimicrobial bioassays help us to understand the potential activity of a natural compound(s) or a crude extract. [21]

The present study shows that whole plant C. occidentalis possess both in vitro cytotoxicity and antibacterial activity. The plant can be further explored for its potential therapeutic uses.

 » Acknowledgements Top

Authors are grateful to National Centre for Cell Science, Pune (India) and National Cancer Institute, Frederick, MD, U.S.A for providing human cancer cell lines.

 » References Top

1.Patwardhan B, Vaidya AD, Mukund Chorghade M. Ayurveda and natural products drug discovery. Curr Sci 2004;86:789-99.  Back to cited text no. 1      
2.Philip PA. Experience with docetaxel in the treatment of gastric cancer. Semin Oncol 2005;32:S24-38.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]  
3.Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A 1999;96:1152-6.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Kinghorn AD, Su BN, Jang DS, Chang LC, Lee D, Gu JQ, et al. Natural Inhibitors of carcinogenesis. Planta Med 2004;70:691-705.   Back to cited text no. 4  [PUBMED]  [FULLTEXT]  
5.Kirtikar KR, Basu BD. Indian Medicinal Plants. 3 rd ed. Deharadun: Vol 8. IBC - International Book Distributor; 1987.p. 85.  Back to cited text no. 5      
6.Bin-Hafeez B, Ahmad I, Haque R, Raisuddin S. Protective effect of Cassia occidentalis L. on cyclophosphamide-induced suppression of humoral immunity in mice. J Ethnopharmacol 2001;75:13-8.   Back to cited text no. 6  [PUBMED]  [FULLTEXT]  
7.Sharma N, Trikha P, Athar M, Raisuddin S. In vitro inhibition of carcinogen-induced mutagenicity by Cassia occidentalis and Emblica officinalis. Drug Chem Toxicol 2000;23:477-84.   Back to cited text no. 7  [PUBMED]  [FULLTEXT]  
8.Sadique J, Chandra T, Thenmozhi V, Elango V. Biochemical modes of action of Cassia occidentalis and Cardiospermum halicacabum in inflammation. J Ethnopharmacol 1987;19:201-12.  Back to cited text no. 8  [PUBMED]  [FULLTEXT]  
9.Caceres A, Lopez B, Juarez X, del Aguila J, Garcia S. Plants used in Guatemala for the treatment of dermatophytic infections. 2. Evaluation of antifungal activity of seven American plants. J Ethnopharmacol 1993;40:207-13.  Back to cited text no. 9      
10.Evans CE, Banso A, Samuel OA. Efficacy of some nupe medicinal plants against Salmonella typhi: An in vitro study. J Ethnopharmacol 2002;80:21-4.   Back to cited text no. 10  [PUBMED]  [FULLTEXT]  
11.Tona L, Cimanga RK, Mesia K, Musuamba CT, De Bruyne T, Apers S, et al. In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo. J Ethnopharmacol 2004;93:27-32.   Back to cited text no. 11  [PUBMED]  [FULLTEXT]  
12.Badami S, Aneesh R, Sankar S, Sathishkumar MN, Suresh B, Rajan S. Antifertility activity of Derris brevipes variety coricea. J Ethanopharmacol 2003;84:99-104.  Back to cited text no. 12      
13.Tona L, Mesia K, Ngimbi NP, Chrimwami B, Okond'ahoka, Cimanga K, et al. In-vivo antimalarial activity of Cassia occidentalis, Morinda morindoides and Phyllanthus niruri. Ann Trop Med Parasitol 2001;95:47-57.   Back to cited text no. 13  [PUBMED]  [FULLTEXT]  
14.Swanston-Flatt SK, Day C, Bailey CJ, Flatt PR. Evaluation of traditional plant treatments for diabetes: Studies in streptozotocin diabetic mice. Acta Diabetol Lat 1989;26:51-5.   Back to cited text no. 14  [PUBMED]    
15.Jafri MA, Subhani M, Javed K, Singh S. Hepatoprotective activity of leaves of Cassia occidentalis against paracetamol and ethyl alcohol intoxication in rats. J Ethnopharmacol 1999;66:355-61.  Back to cited text no. 15  [PUBMED]  [FULLTEXT]  
16.Bhahwal AS, Kumar A, Gupta P, Sharma M, Sethi VK, Saxena AK, et al. Cytotoxic and apoptotic activities of novel amino analogues of boswellic acids. Bioorganic and Medicinal Chemistry Letters 2007;17:6411-6.   Back to cited text no. 16      
17.Sahoo S, Kar DM, Mohapatra S, Rout SP, Dash SK. Antibacterial activity of Hybanthus enneaspermus against selected UTI pathogens. Indian J Pharma Sci 2006;68:653-5.   Back to cited text no. 17      
18.Cowan MM. Plant materials as antimicrobial agents. Chem Med Rev 1999;12:564-82.  Back to cited text no. 18      
19.Meyer BN, Ferrigni NR, Putnam JE, Jacobsen JB, Nicholsand DE, Mclaughlin JL. Brine shrimp; a convenient general bioassay for active plant constituents. Planta Medica 1982;45:31-4.  Back to cited text no. 19      
20.Sanchez C, Gupta M, Vasquez M, de Noriega, Montenegro G. Bioassay with Artemia to predict antibacterial and pharmacological activity. Rev Med Panama 1993;18:62-9.  Back to cited text no. 20      
21.Nuhu AA, Aliyu R. Effects of Cassia occidentalis aqueous leaf extract on biochemical markers of tissue damage in rats. Trop J Pharma Res 2008;7:1137-42.  Back to cited text no. 21      


  [Figure 1]

  [Table 1]

This article has been cited by
1 Phytoconstituent Isolation and Cytotoxicity Evaluation of the Egyptian Cassia occidentalis L. Possessing Selective Activity against Lung Carcinoma
Hanaa M. Sayed, Mahmoud A. Ramadan, Heba H. Salem, Marwa A. A. Fayed, Ashanul Haque
Journal of Chemistry. 2023; 2023: 1
[Pubmed] | [DOI]
2 Ethnomedical Applications and Conservation Status of Leguminosae- Caesalpinioideae Plants in Uttar Pradesh, India
Shivaraman Pandey, Lav Singh, Ravi Prakash Srivastava, Arun Kumar Kushwaha, Pooja Dixit, Gauri Saxena, Lal Babu Chaudhary
Recent Patents on Biotechnology. 2023; 17(2): 106
[Pubmed] | [DOI]
3 Exploring the Phytochemicals and Anti-Cancer Potential of the Members of Fabaceae Family: A Comprehensive Review
Muhammad Usman, Waseem Razzaq Khan, Nousheen Yousaf, Seemab Akram, Ghulam Murtaza, Kamziah Abdul Kudus, Allah Ditta, Zamri Rosli, Muhammad Nawaz Rajpar, Mohd Nazre
Molecules. 2022; 27(12): 3863
[Pubmed] | [DOI]
4 Anticancer activity of Nigerian medicinal plants: a review
Franklyn O. Ohiagu, Paul C. Chikezie, Chinwendu M. Chikezie, Christian E. Enyoh
Future Journal of Pharmaceutical Sciences. 2021; 7(1)
[Pubmed] | [DOI]
5 Integration of medicinal plants into the traditional system of medicine for the treatment of cancer in Sokoto State, Nigeria
Ibrahim Malami, Nasiru Muhammad Jagaba, Ibrahim Babangida Abubakar, Aliyu Muhammad, Alhassan Muhammad Alhassan, Peter Maitama Waziri, Ibrahim Zakiyya Yakubu Yahaya, Halilu Emmanuel Mshelia, Sylvester Nefy Mathias
Heliyon. 2020; 6(9): e04830
[Pubmed] | [DOI]
6 Nigerian antimalarial plants and their anticancer potential: A review
Kayode Ezekiel Adewole
Journal of Integrative Medicine. 2020; 18(2): 92
[Pubmed] | [DOI]
7 Larvicidal Activity of Cassia occidentalis (Linn.) against the Larvae of Bancroftian Filariasis Vector Mosquito Culex quinquefasciatus
Deepak Kumar,Rakesh Chawla,P. Dhamodaram,N. Balakrishnan
Journal of Parasitology Research. 2014; 2014: 1
[Pubmed] | [DOI]
8 Natural products: Promising resources for cancer drug discovery
Mondal, S., Bandyopadhyay, S., Ghosh, M.K., Mukhopadhyay, S., Roy, S., Mandal, C.
Anti-Cancer Agents in Medicinal Chemistry. 2012; 12(1): 49-75


Print this article  Email this article


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow